Arti K. Rai | Scholars@Duke

Arti K. Rai
Elvin R. Latty Distinguished Professor of Law

Arti Rai, Elvin R. Latty Professor of Law and Faculty Director, The Center for Innovation Policy at Duke Law, is an internationally recognized expert in intellectual property (IP) law, innovation policy, administrative law, and health law. Rai has also taught at Harvard, Yale, and the University of Pennsylvania Law Schools. Rai's research has been funded by NIH, the Kauffman Foundation, the Greenwall Foundation and the Woodrow Wilson Center. Her numerous publications have appeared in both peer-reviewed journals and law reviews, including Science, the New England Journal of Medicine, the Journal of Legal Studies, Nature Biotechnology, and the Columbia, Duke, University of Pennsylvania, University of Texas, Georgetown, and Northwestern law reviews. She is the editor of Intellectual Property Law and Biotechnology: Critical Concepts (Edward Elgar, 2011) and the co-author of a 2012 Kauffman Foundation monograph on cost-effective health care innovation.

Rai’s current work, funded by the Greenwall Foundation, focuses on the intersection of trade secrecy incentives and explainability in AI-enabled health care delivery.

From 2009-2010, Rai served as the Administrator of the Office of External Affairs at the U.S. Patent and Trademark Office (USPTO). As External Affairs Administrator, Rai led policy analysis of the patent reform legislation that ultimately became the America Invents Act and worked to establish the USPTO’s Office of the Chief Economist. Prior to that time, she had served on President-Elect Obama’s transition team reviewing the USPTO. Prior to entering academia, Rai clerked for the Honorable Marilyn Hall Patel of the U.S. District Court for the Northern District of California; was a litigation associate at Jenner & Block (doing patent litigation as well as other litigation); and was a litigator at the Federal Programs Branch of the U.S. Department of Justice's Civil Division.

Rai regularly testifies before Congress and relevant administrative bodies on innovation-related law and policy issues and regularly advises federal agencies on policy issues raised by the research that they fund. She has served a member of the National Advisory Council for Human Genome Research and as a public member of the Administrative Conference of the United States. Rai has also served on, or as a reviewer for, numerous National Academies of Science committees. In 2013, she was elected to the American Law Institute. She won the World Technology Network Award for Law in 2011.

Rai graduated from Harvard College, magna cum laude, with a degree in biochemistry and history (history and science), attended Harvard Medical School for the 1987-1988 academic year, and received her J.D., cum laude, from Harvard Law School in 1991.

Current Appointments & Affiliations

Elvin R. Latty Distinguished Professor of Law, Duke Law School, Duke University 2008
Professor of Law, Duke Law School, Duke University 2003
Faculty Network Member of The Energy Initiative, Duke University Energy Initiative, Initiatives 2015
Associate of the Duke Initiative for Science & Society, Duke Science & Society, Initiatives 2017
Core Faculty in Innovation & Entrepreneurship, Duke Innovation & Entrepreneurship, Initiatives 2018

Contact Information

Duke Law School 210 Science Dr, Duke Box 90362, Durham, NC 27708
Duke Law School Room 3022, Duke Box 90362, Durham, NC 27708
rai@law.duke.edu (919) 613-7274
See the Duke Law profile page
View this faculty member's publications on the Duke Law web site

Background
Education, Training, & Certifications
- J.D., Harvard University 1991
Recognition
In the News
- MAR 28, 2016
  
  Infectious Disease Symposium Convenes at Duke April 1
- FEB 4, 2016 BuzzFeed
  
  Arti Rai comments on patent fight over gene-editing technology
- NOV 16, 2015 The New York Times
  
  Arti Rai proposes method for decreasing prices of expensive class of drugs
- MAY 21, 2015 Nature
  
  Arti Rai comments on likelihood of enacting patent-troll legislation
- MAY 12, 2015 BuzzFeed
  
  Arti Rai discusses partnerships between universities and big pharma
- APR 30, 2015 The New York Times
  
  Arti Rai quoted: With patent litigation surging, creators turn to Washington for help
- APR 15, 2015 Science
  
  Arti Rai discusses wrangling between universities, electronics companies over ‘patent troll’ bill
- APR 30, 2014 The New York Times
  
  Arti Rai comments: Europe's antitrust chief censures Google's Motorola Mobility over key patents
- NOV 13, 2013
  
  Laws New Center for Innovation Policy Promotes Long-Term Economic Growth
- JUL 5, 2013 Boston Herald
  
  Colleges get tough on patent infringement
Expertise
Global Scholarship
- Expertise
  - United States of America (Country)
Research
Selected Grants
- Low-Quality Biopharmaceutical Patents and the PTAB 2020
- Explainability and Trade Secrecy in AI-Enabled Clinical Decision Support, Diagnostic, and Predictive Software awarded by Greenwall Foundation 2019 - 2020
- Intellectual Property and Access to Noninvasive Prenatal Genetic Testing awarded by National Institutes of Health 2013 - 2017
- Conference on New Approaches and Incentives in Drug Development awarded by Ewing Marion Kauffman Foundation 2013 - 2014
- Intellectual Property Challenges for the Development of Genomic Diagnostics awarded by National Institutes of Health 2009 - 2012
Publications & Artistic Works
Selected Publications
- Books
  - Rai, A. Intellectual Property and Biotechnology. Edward Elgar, 2011.
    Link to Item
  - Rai, A., C. Slobogin, and R. Reisner. Law and the Mental Health System: Civil and Criminal Aspects, 2009.
    Link to Item
- Academic Articles
  - Rai, A. “Machine Learning at the Patent Office: Lessons for Patents and Administrative Law.” Iowa Law Review 104, no. 5 (2019): 2617–41.
    Link to Item
  - Rai, A., and W. II. “How Logically Impossible Patents Block Biosimilars.” Nature Biotechnology 37, no. 8 (2019): 862–63.
  - Rai, A., C. Cotropia, D. Crouch, S. Graham, M. Janis, J. Kesan, M. Lemley, A. Mossoff, T. Sichelman, and S. Vishnubhakat. “Response to the Proposed Changes to the Claim Construction Standard for Interpreting Claims in Trial Proceedings Before the Patent Trial and Appeal Board,” 2018.
    Link to Item
  - Rai, A. “Intellectual Property Issues in Genomics.” Annual Review of Genomics & Human Genetics 18 (2017).
  - Rai, A. “Risk Regulation and Innovation: The Case of Rights-Encumbered Biomedical Data Silos.” Notre Dame Law Review 92 (2017): 1641–67.
    Link to Item
  - Rai, A., and R. Cook-Deegan. “Racing for Academic Glory and Patents: Lessons from CRISPR.” Science 358, no. 6365 (2017): 874–76.
  - Rai, A., R. Feldman, M. Lemley, and J. Masur. “Open Letter on Ethical Norms in Intellectual Property Scholarship.” Harvard Journal of Law & Technology 29, no. 2 (2016): 1–13.
    Link to Item
  - Rai, A., S. Vishnubhakat, and J. Kesan. “Strategic Decision Making in Dual PTAB and District Court Proceedings.” Berkeley Technology Law Journal 31, no. 1 (2016): 45–124.
    Link to Item
  - Rai, A., and J. Sherkow. “The Changing Life Science Patent Landscape.” Nature Biotechnology 34 (2016): 292–93.
  - Rai, A., and S. Benjamin. “Administrative Power in the Era of Patent Stare Decisis.” Duke Law Journal 65 (2016): 1561–97.
    Link to Item
  - Rai, A., and W. II. “Manufacturing Barriers to Biologics Competition and Innovation.” Iowa Law Review 101 (2016): 1023–63.
    Link to Item
  - Price, W Nicholson, and Arti K. Rai. “Drug Development. Are trade secrets delaying biosimilars?.” Science (New York, N.Y.) 348, no. 6231 (April 9, 2015): 188–89. https://doi.org/10.1126/science.aab1684.
    Full Text
  - Rai, A. “Are Trade Secrets Delaying Biosimilars?.” Science 348, no. 6231 (2015): 188–89.
  - Rai, A., and S. Vishnubhakat. “When Biopharma Meets Software: Bioinformatics at the Patent Office.” Harvard Journal of Law & Technology 29, no. 1 (2015): 206–41.
    Link to Item
  - Rai, A. “Diagnostic Patents at the Supreme Court.” Marquette Intellectual Property Law Review 18 (2014): 1–9.
    Link to Item
  - Rai, A. “Competing with the "Patent Court": A Newly Robust Ecosystem.” Chicago Kent Journal of Intellectual Property 13, no. 2 (2014): 386–93.
    Link to Item
  - Rai, A., and G. Rice. “Use Patents Can Be Useful: The Case of Rescued Drugs.” Science Translational Medicine 6 (2014).
  - Rai, A. “Biomedical Patents at the Supreme Court: A Path Forward.” Stanford Law Review Online 66 (2013): 111–17.
    Link to Item
  - Rai, A. “Improving (Software) Patent Quality Through the Administrative Process.” Houston Law Review 51 (2013): 503–43.
    Link to Item
  - Rai, A., and M. Bagley. “The Nagoya Protocol and Synthetic Biology Research: A Look at the Potential Impacts,” 2013.
    Link to Item
  - Rai, A., and R. Cook-Deegan. “Moving Beyond "Isolated" Gene Patents.” Science 341 (2013).
  - Rai, A. “Valuing Health Care: Improving Productivity and Quality,” 2012.
    Link to Item
  - Rai, A. “Use Patents, Carve-Outs, and Incentives--A Battle in the Drug-Patent Wars.” New England Journal of Medicine 367 (2012): 491–93.
    Link to Item
  - Rai, A. “Patent Validity Across the Executive Branch: Ex Ante Foundations for Policy Development.” Duke Law Journal 61 (2012): 1237–81.
    Link to Item
  - Rai, A., and B. Sampat. “Accountability in Patenting of Federally Funded Research.” Nature Biotechnology 30 (2012): 953–56.
    Link to Item
  - Rai, A. “Who's Afraid of the Federal Circuit?.” Yale Law Journal Online 121 (2011): 335–45.
    Link to Item
  - Rai, A. “Unstandard Standardization: The Case of Biology.” Communications of the Acm 53 (2010): 37–39.
    Link to Item
  - Kieff, F. S., D. Martens, A. K. Rai, and R. R. Rader. “Panel discussion: Specialized courts: Lessons from the federal circuit.” Journal of Intellectual Property 8, no. 2 (June 3, 2009): 317–42.
  - Ortí, Leticia, Rodrigo J. Carbajo, Ursula Pieper, Narayanan Eswar, Stephen M. Maurer, Arti K. Rai, Ginger Taylor, et al. “A kernel for the Tropical Disease Initiative..” Nature Biotechnology 27, no. 4 (April 2009): 320–21. https://doi.org/10.1038/nbt0409-320.
    Full Text
  - Cook-Deegan, Robert, and Arti K. Rai. “DNA sequence patents are not in the grave yet..” Nature Biotechnology 27, no. 2 (February 2009). https://doi.org/10.1038/nbt0209-122.
    Full Text
  - Ortí, Leticia, Rodrigo J. Carbajo, Ursula Pieper, Narayanan Eswar, Stephen M. Maurer, Arti K. Rai, Ginger Taylor, et al. “A kernel for open source drug discovery in tropical diseases..” Plos Neglected Tropical Diseases 3, no. 4 (January 2009). https://doi.org/10.1371/journal.pntd.0000418.
    Full Text
  - Rai, A. “Growing Pains in the Administrative State: The Patent Office's Troubled Quest For Managerial Control.” University of Pennsylvania Law Review 157 (2009): 2051–81.
    Link to Item
  - Rai, A., J. Allison, B. Sampat, and C. Crossman. “University Software Ownership and Litigation: A First Examination.” Perspectives: Teaching Legal Research and Writing 87 (2009): 1519–70.
    Link to Item
  - Rai, A., S. Chandrasekharan, S. Kumar, and C. Valley. “Proprietary Science, Open Science and the Role of Patent Disclosure: The Case of Zinc Finger Proteins.” Nature Biotechnology 27 (2009): 140–44.
    Link to Item
  - Rai, A., and S. Benjamin. “Structuring U.S. Innovation Policy: Creating a White House Office of Innovation Policy,” 2009.
    Link to Item
  - Benjamin, S., and A. Rai. “Fixing Innovation Policy: A Structural Perspective.” George Washington Law Review 77 (2008): 1–88.
    Link to Item
  - Rai, A. “Building a Better Innovation System: Combining Facially Neutral Patent Standards with Therapeutics Regulation.” Houston Law Review 45 (2008): 1037–57.
    Link to Item
  - Rai, A., and S. Benjamin. “Fixing Innovation Policy: A Structural Perspective.” George Washington Law Review 77 (2008): 1–88.
    Link to Item
  - Reichman, J., A. So, B. Sampat, R. Cook-Deegan, R. Weissman, and A. Kapczynski. “Is Bayh-Dole Good for Developing Countries? Lessons from the U.S. Experience.” Plos Biology 6 (2008): 2078–84.
    Link to Item
  - Reichman, J., P. Uhlir, and C. Crossman. “Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery.” Yale Journal of Health Policy, Law & Ethics 8 (2008): 53–89.
    Link to Item
  - Rai, A. “Knowledge Commons: The Case of the Biopharmaceutical Industry.” First Monday 12 (2007).
    Link to Item
  - Rai, A. “The Ends of Intellectual Property: Health as a Case Study.” Law and Contemporary Problems 70 (2007): 125–30.
    Link to Item
  - Rai, A., and J. Boyle. “Synthetic Biology: Caught Between Property Rights, the Public Domain, and the Commons.” Plos Biology 5 (2007): 389–93.
    Link to Item
  - Rai, A., and S. Benjamin. “Who's Afraid of the APA? What the Patent System Can Learn from Administrative Law.” Georgetown Law Journal 95 (2007): 269–336.
    Link to Item
  - Rai, A., and S. Kumar. “Synthetic Biology: The Intellectual Property Puzzle.” Texas Law Review 85 (2007): 1745–68.
    Link to Item
  - Kepler, T. B., M. A. Marti-Renom, S. M. Maurer, A. K. Rai, G. Taylor, and M. H. Todd. “Open source research - The power of us.” Australian Journal of Chemistry 59, no. 5 (June 19, 2006): 291–94. https://doi.org/10.1071/CH06095.
    Full Text
  - Rai, A., and R. Eisenberg. “Harnessing and Sharing the Benefits of State Sponsored Research.” Berkeley Technology Law Journal 21 (2006): 1187–1213.
    Link to Item
  - Rai, A., and C. Crossman. “A Brief History of BioPerl,” 2005.
    Link to Item
  - Rai, A. “Finding Cures for Tropical Diseases: Is Open Source an Answer?.” Plos Medicine 1 (2004): 180–83.
    Link to Item
  - Rai, A. “'Patenting Organisms and 'Basic Research,' and 'Private Ownership of Inventions',” 2004, 1980–83.
  - Rai, A. “Engaging Facts and Policy: A Multi-Institutional Approach to Patent System Reform.” Columbia Law Review 103 (2003): 1035–1135.
  - Rai, A., and R. Eisenberg. “Bayh-Dole Reform and the Progress of Biomedicine.” Law & Contemporary Problems 66 (2003): 289–315.
    Link to Item
  - Rai, A. “Genome Patents: A Case Study in Patenting Research Tools.” Academic Medicine 77 (2002): 1368–72.
  - Rai, A. “Genetic Interventions: (Yet) Another Challenge to Allocating Health Care.” San Diego Law Review 39 (2002): 657–67.
    Link to Item
  - Rai, A. “Locating Gene Patents Within the Patent System.” American Journal of Bioethics 2 (2002).
  - Rai, A. “Pharmacogenetic Interventions, Orphan Groups, and Distributive Justice: The Role of Cost-Benefit Analysis.” Social Philosophy & Policy 19 (2002).
    Link to Item
  - Rai, A. “Specialized Trial Courts: Concentrating Expertise on Fact.” Berkeley Technology Law Journal 17 (2002): 877–98.
    Link to Item
  - Rai, A. “Health Care Fraud and Abuse: A Tale of Behavior Induced by Payment Structure.” Journal of Legal Studies 30 (2001): 579–87.
    Link to Item
  - Rai, A. “Evolving Scientific Norms and Intellectual Property Rights: A Reply to Professor Kieff.” Northwestern University Law Review 95 (2001): 707–13.
    Link to Item
  - Rai, A. “Fostering Cumulative Innovation in the Biopharmaceutical Industry: The Role of Patents and Antitrust.” Berkeley Technology Law Journal 16 (2001).
    Link to Item
  - Rai, A. “The Information Revolution Reaches Pharmaceuticals: Balancing Innovation Incentives, Cost, and Access in the Post-Genomics Era.” University of Illinois Law Review 2001 (2001): 173–210.
    Link to Item
  - Rai, A. “Addressing the Patent Gold Rush: The Role of Deference to PTO Patent Denials.” Washington University Journal of Law & Policy 2 (2000): 199–227.
    Link to Item
  - Rai, A. “Intellectual Property Rights in Biotechnology: Addressing New Technology.” Wake Forest Law Review 34 (1999): 827–47.
    Link to Item
  - Rai, A. “Regulating Scientific Research: Intellectual Property Rights and the Norms of Science.” Northwestern University Law Review 94 (1999): 77–152.
    Link to Item
  - Rai, A. “Reflective Choice in Health Care: Using Information Technology to Present Allocation Options.” American Journal of Law & Medicine 25 (1999).
    Link to Item
  - Rai, A., M. Siegler, and J. Lantos. “The Physician as a Health Care Proxy.” Hastings Center Report 29 (1999).
  - Rai, A. “Rationing Through Choice: A New Approach to Cost-Effectiveness Analysis in Health Care.” Indiana Law Journal 72 (1997): 1015–97.
    Link to Item
  - Rai, A. “Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature.” Annals of Internal Medicine 116 (1992).
  - Rai, Arti, and James Boyle. “Synthetic Biology: Caught between Property Rights, the Public Domain, and the Commons.” Plos Biology 5, no. 3 (n.d.): e58–e58. https://doi.org/10.1371/journal.pbio.0050058.
    Full Text
- Book Sections
  - Rai, A. “Patent Institutions: Shifting Interactions Between Legal Actors.” In Research Handbook on the Economics of Intellectual Property Law, 473–88. Edward Elgar Publishing, 2019.
    Link to Item
  - Rai, A., and S. Vishnubhakat. “The USPTO’s Patent Trial and Appeal Board.” In Research Handbook on the Economics of Intellectual Property Law, 92–103. Edward Elgar Publishing, 2019.
  - Rai, A. “The "Follow-On" Challenge: Statutory Exclusivities and Patent Dances.” In FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies, 403–12, 2015.
  - Rai, A., and B. Sampat. “Accountability, Government Rights, and the Public Interest: A Thirty-Year Retrospective.” In The Chicago Handbook of University Technology Transfer and Academic Entrepreneurship, 75–96, 2015.
  - Rai, A. “U.S. Executive Branch Patent Policy, Global and Domestic.” In Patent Law in Global Perspective, 85–96. Oxford University Press, 2014.
    Link to Item
  - Rai, A., J. Reichman, R. Newell, and J. Wiener. “Intellectual Property and Alternatives: Strategies for Green Innovation.” In Intellectual Property Rights: Legal and Economic Challenges for Development, 356–91, 2014.
  - Rai, A. “Critical Commentary on 'Open Source' in the Life Sciences.” In Gene Patents and Collaborative Licensing Models: Patent Pools, Clearinghouses, Open Source Models and Liability Regimes, 213–18, 2009.
  - Rai, A. “"Open and Collaborative" Biomedical Research: Theory and Evidence.” In Advancing Knowledge and the Knowledge Economy, 391–414, 2006.
  - Rai, A. “Open and Collaborative Research: A New Model for Biomedicine.” In Intellectual Property Rights in Frontier Industries, 131–58. AEI-Brookings Press, 2005.
    Link to Item
  - Rai, A. “Proprietary Rights and Collective Action: The Case of Biotechnology Research With Low Commercial Value.” In International Public Goods and Technology Transfer in a Globalized Intellectual Property Regime, 288–306, 2005.
    Link to Item
  - Rai, A. “Allocating Power over Fact-Finding in the Patent System,” 19:907–22, 2004.
    Link to Item
  - Rai, A. “The Increasingly Proprietary Nature of Publicly Funded Biomedical Research: Benefits and Threats.” In Buying in or Selling Out?: The Commercialization of the American University, 117–26, 2004.
  - Rai, A., and R. Eisenberg. “Proprietary Considerations.” In 2 Handbook of Stem Cells: Embryonic Stem Cells, 793–98, 2004.
    Link to Item
- Other Articles
  - Rai, A., and E. Chen. “The Need for Speed: Process and Product Quality in Track 1.” Law 360, 2016.
  - Rai, A. “Letter to U.S. Senate Committee on the Judiciary Concerning Inter Partes Review and Orange Book-Listed Patents.” Letter to the U.S. Senate Committee on the Judiciary, 2015.
  - Rai, A., and G. Rice. “Use Patents Can Be Useful: The Case of Rescued Drugs.” Science Translational Medicine, 2014.
  - Rai, A. “Patentable Subject Matter at the Supreme Court: An Exceptional Case?.” Scotusblog, 2013.
- Reports
  - Rai, A., C. Chien, J. Contreras, C. Corrado, S. Graham, D. Hegde, and S. Vishnubhakat. “Comment to the SEC in Support of the Enhanced Disclosure of Patent Technology License Information,” 2016.
    Link to Item
  - Rai, A., C. Chien, R. Gilbert, C. Shapiro, T. Cotter, S. Ghosh, E. Goldman, et al. “Rand Patents and Exclusion Orders: Submission of 19 Economics and Law Professors to the International Trade Commission,” 2012.
    Link to Item
  - Rai, A., R. Newell, J. Reichman, and J. Wiener. “Intellectual Property and Alternatives: Strategies for Green Innovation,” 2008.
    Open Access Copy Link to Item
Teaching & Mentoring
Recent Courses
Scholarly, Clinical, & Service Activities
Outreach & Engaged Scholarship
- Bass Connections Faculty Team Member . Innovation and Technology Policy Lab . August 2015 - May 2016 2015 - 2016

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

In the News

Global Scholarship

Expertise

Selected Grants

Selected Publications

Books

Academic Articles

Book Sections

Other Articles

Reports

Recent Courses

Outreach & Engaged Scholarship